FDA Law Blog: Biosimilars

SEPTEMBER 30, 2024

physicians services or inpatient hospitals services) and for which Medicaid payment may be made as part of payment for the service “and not as direct reimbursement for the drug.” Remarkably, manufacturers may not dispute a CMS notification. 1396r-8(k)(3).

Vaccines 59

Vaccines Inpatient Packaging Documentation 59

RX Note

FEBRUARY 23, 2023

. - Drug registration number Medicines (Advertisement & Sale) Act 1956 and Regulations - To learn prohibitions of medicine advertisement and Medicine Advertisement Board Registration of Pharmacists Act 1951 and Regulations - Pharmacy Board Malaysia and legislation aspects of provisional, full and temporary registration Code of Ethics for Pharmacists (..)

HIV Treatment and Prevention Agents 58

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy 58

FDA Law Blog: Biosimilars

MARCH 6, 2025

Both guidance documents recommend data management practices for collecting data for use in developing, tuning, and testing an artificial intelligence model and making changes to said model. inpatient hospital, out-patient clinic), date range for the data, and location of the data collection sites (e.g., data acquisition device).

Documentation 59

Documentation Inpatient Labelling Hospitals 59